Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors

BACKGROUND: Programmed cell death 1 inhibitors have revolutionized therapy for cancer by their outstanding effectiveness. However, they may cause adverse effects, among which inflammatory myopathy is one of the most disabling. To elucidate its mechanism, we analysed muscle biopsies and compared them...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsubara, Shiro, Seki, Morinobu, Suzuki, Shigeaki, Komori, Takashi, Takamori, Mikio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751882/
https://www.ncbi.nlm.nih.gov/pubmed/31533865
http://dx.doi.org/10.1186/s40425-019-0736-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751882/
https://www.ncbi.nlm.nih.gov/pubmed/31533865
http://dx.doi.org/10.1186/s40425-019-0736-4

Ejemplares similares